Valuation and Returns of Drug Development Companies: Lessons for Bioentrepreneurs and Investors

OBJECTIVES: This study evaluates the association of Biopharma company valuation with the lead drug’s development stage, orphan status, number of indications, and disease area. We also estimated annual returns Bioentrepreneurs and investors can expect from founding and investing in drug development v...

Descripción completa

Detalles Bibliográficos
Autores principales: Michaeli, Daniel Tobias, Yagmur, Hasan Basri, Achmadeev, Timur, Michaeli, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854317/
https://www.ncbi.nlm.nih.gov/pubmed/35018622
http://dx.doi.org/10.1007/s43441-021-00364-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854317/
https://www.ncbi.nlm.nih.gov/pubmed/35018622
http://dx.doi.org/10.1007/s43441-021-00364-y

Ejemplares similares